Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 219

1.

Atypical hemolytic uremic syndrome: from diagnosis to treatment.

Franchini M.

Clin Chem Lab Med. 2015 Oct;53(11):1679-88. doi: 10.1515/cclm-2015-0024. Review.

2.
3.

Atypical hemolytic uremic syndrome (aHUS): essential aspects of an accurate diagnosis.

Laurence J, Haller H, Mannucci PM, Nangaku M, Praga M, Rodriguez de Cordoba S.

Clin Adv Hematol Oncol. 2016 Nov;14 Suppl 11(11):2-15. Review.

PMID:
27930620
4.

Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand.

Fox LC, Cohney SJ, Kausman JY, Shortt J, Hughes PD, Wood EM, Isbel NM, de Malmanche T, Durkan A, Hissaria P, Blombery P, Barbour TD.

Nephrology (Carlton). 2018 Jun;23(6):507-517. doi: 10.1111/nep.13234. Review.

PMID:
29419916
5.

An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document.

Campistol JM, Arias M, Ariceta G, Blasco M, Espinosa L, Espinosa M, Grinyó JM, Macía M, Mendizábal S, Praga M, Román E, Torra R, Valdés F, Vilalta R, Rodríguez de Córdoba S.

Nefrologia. 2015;35(5):421-47. doi: 10.1016/j.nefro.2015.07.005. Epub 2015 Oct 9. English, Spanish.

6.

Postpartum thrombotic microangiopathy revealed as atypical hemolytic uremic syndrome successfully treated with eculizumab: a case report.

Kourouklaris A, Ioannou K, Athanasiou I, Panagidou A, Demetriou K, Zavros M.

J Med Case Rep. 2014 Sep 14;8:307. doi: 10.1186/1752-1947-8-307.

7.

Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand.

Fox LC, Cohney SJ, Kausman JY, Shortt J, Hughes PD, Wood EM, Isbel NM, de Malmanche T, Durkan A, Hissaria P, Blombery P, Barbour TD.

Intern Med J. 2018 Jun;48(6):624-636. doi: 10.1111/imj.13804. Review.

PMID:
29582550
8.

Natural history of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.

Wada H, Matsumoto T, Yamashita Y.

Semin Thromb Hemost. 2014 Nov;40(8):866-73. doi: 10.1055/s-0034-1395154. Epub 2014 Nov 6. Review.

PMID:
25377323
9.

Diagnosis and treatment of TMA based on Japanese clinical guides.

Wada H, Hasegawa K, Watanabe M.

Rinsho Ketsueki. 2017;58(7):849-856. doi: 10.11406/rinketsu.58.849. Japanese.

PMID:
28781284
10.

[Atypical hemolytic uremic syndrome].

Blasco Pelicano M, Rodríguez de Córdoba S, Campistol Plana JM.

Med Clin (Barc). 2015 Nov 20;145(10):438-45. doi: 10.1016/j.medcli.2014.08.006. Epub 2014 Nov 26. Review. Spanish.

11.

[Atypical HUS caused by complement-related abnormalities].

Yoshida Y, Matsumoto M.

Rinsho Ketsueki. 2015 Feb;56(2):185-93. doi: 10.11406/rinketsu.56.185. Review. Japanese.

PMID:
25765799
12.

Atypical hemolytic uremic syndrome (aHUS): making the diagnosis.

Laurence J.

Clin Adv Hematol Oncol. 2012 Oct;10(10 Suppl 17):1-12. Review.

PMID:
23187605
13.

Safety and effectiveness of eculizumab for pediatric patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance.

Ito S, Hidaka Y, Inoue N, Kaname S, Kato H, Matsumoto M, Miyakawa Y, Mizuno M, Okada H, Shimono A, Matsuda T, Maruyama S, Fujimura Y, Nangaku M, Kagami S.

Clin Exp Nephrol. 2019 Jan;23(1):112-121. doi: 10.1007/s10157-018-1610-2. Epub 2018 Jul 23.

14.
15.

Atypical Hemolytic Uremic Syndrome: Differential Diagnosis from TTP/HUS and Management.

Yenerel MN.

Turk J Haematol. 2014 Sep 5;31(3):216-25. doi: 10.4274/tjh.2013.0374.

16.

[Atypical hemolytic uremic syndrome (aHUS): new insights into pathogenesis leading to novel therapeutic approaches].

Kistler AD.

Praxis (Bern 1994). 2016 Mar 30;105(7):389-96. doi: 10.1024/1661-8157/a002308. Review. German.

PMID:
27005733
17.

Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome.

Greenbaum LA, Fila M, Ardissino G, Al-Akash SI, Evans J, Henning P, Lieberman KV, Maringhini S, Pape L, Rees L, van de Kar NC, Vande Walle J, Ogawa M, Bedrosian CL, Licht C.

Kidney Int. 2016 Mar;89(3):701-11. doi: 10.1016/j.kint.2015.11.026. Epub 2016 Jan 28.

18.

A mechanistic approach to the diagnosis and management of atypical hemolytic uremic syndrome.

Tsai HM.

Transfus Med Rev. 2014 Oct;28(4):187-97. doi: 10.1016/j.tmrv.2014.08.004. Epub 2014 Sep 3. Review.

PMID:
25280590
19.

Thrombotic microangiopathy and associated renal disorders.

Barbour T, Johnson S, Cohney S, Hughes P.

Nephrol Dial Transplant. 2012 Jul;27(7):2673-85. doi: 10.1093/ndt/gfs279. Review.

20.

Diagnosis of atypical hemolytic uremic syndrome and response to eculizumab therapy.

Nguyen MH, Mathew JJ, Denunzio TM, Carmichael MG.

Hawaii J Med Public Health. 2014 Sep;73(9 Suppl 1):22-4.

Supplemental Content

Support Center